Search
for
Sort by
Research 451–480 of 1000+
- Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China
- Compounding as a Current Therapeutic Option in Dermatology
- Book Reviews
- ANNOUNCEMENTS
- Iododerma in pregnancy secondary to iodinated multivitamins
- Cicatricial alopecia of the scalp as a manifestation of IgG4-related disease mimicking acne keloidalis nuchae
- Development and Invitro Evaluation of Solid Lipid Nano Particles Loaded Topical Gel Containing Combination of Drugs Used In The Better Therapy of Psoriasis
- Successful treatment of Notoedres cati-infested kitten using selamectin spot-on: A case report
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Cutaneous Manifestations of Chronic Kidney Disease: A Narrative Review
- Molecular and Pathological Studies on Sarcoptes scabiei in Sheep in Ismailia Province, Egypt.
- Low-level light therapy and hair loss
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Production and potential application of wood tar in dermatology and cosmetic
- The cutaneous serotoninergic/melatoninergic system: securing a place under the sun
- Cutaneous complications of chemotherapeutic agents
- Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithium
- A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Systemic causes of hair loss
- Niosomes as Carrier in Dermal Drug Delivery
- Multiple minute digitate hyperkeratosis
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Therapeutic inhibition of keratinocyte TRPV3 sensory channel by local anesthetic dyclonine
- Topical imiquimod—Be aware of the unexpected
- Nociceptive and Nonnociceptive Roles of TRPV3 and Its “Druggability”
- Cutaneous signals of immune system disease
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- The dermatologic manifestation of hyperandrogenism: A retrospective chart review
- Ottawa, Ontario, Canada, February 13–16, 2013